Alterity Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATHE and other ETFs, options, and stocks.About ATHE
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders.
CEODavid A. Stamler
CEODavid A. Stamler
Employees9
Employees9
HeadquartersMelbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded1997
Founded1997
Employees9
Employees9
ATHE Key Statistics
Market cap60.36M
Market cap60.36M
Price-Earnings ratio-4.12
Price-Earnings ratio-4.12
Dividend yield—
Dividend yield—
Average volume17.51K
Average volume17.51K
High today—
High today—
Low today—
Low today—
Open price$3.07
Open price$3.07
Volume0.00
Volume0.00
52 Week high$7.00
52 Week high$7.00
52 Week low$2.04
52 Week low$2.04
Stock Snapshot
With a market cap of 60.36M, Alterity Therapeutics(ATHE) trades at $3.07. The stock has a price-to-earnings ratio of -4.12.
Alterity Therapeutics(ATHE) stock opened on 2025-12-17 at $3.07. The price climbed to — and dipped to —.
Alterity Therapeutics(ATHE) shares are trading with a volume of 0, against a daily average of 17.51K.
In the last year, Alterity Therapeutics(ATHE) shares hit a 52-week high of $7.00 and a 52-week low of $2.04.
In the last year, Alterity Therapeutics(ATHE) shares hit a 52-week high of $7.00 and a 52-week low of $2.04.